Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Kath Khemicals LLC
WARNING LETTER
•Kath Khemicals LLC•April 3, 2025

Kath Khemicals LLC – FDA Warning Letter, Apr 3, 2025

Record Details

The FDA issued a Warning Letter to Kath Khemicals LLC on September 22, 2025, following an inspection from March 31 to April 3, 2025, at their Macomb, MI drug manufacturing facility. The letter identifies significant violations of Current Good Manufacturing Practice (CGMP) regulations, specifically 21 CFR parts 210 and 211, indicating their drug products are adulterated.

Key violations include the company"s failure to adequately test finished drug products, such as McD Foaming Antibacterial Hand Soap and McD Anti-Microbial Handwash, for identity, strength, and microbial contamination before distribution. Additionally, they lacked appropriate microbiological testing for the water used in their manufacturing processes. The FDA found the company"s proposed corrective actions for finished product and water testing to be insufficient.

Another critical issue was the failure to conduct proper identity testing for incoming components, notably glycerin. The company"s methods did not include testing for hazardous impurities like diethylene glycol (DEG) and ethylene glycol (EG), which have been associated with severe poisoning incidents. The proposed plan for contract lab testing of glycerin was also deemed inadequate due to a lack of detailed procedures and a retrospective review.

Required actions from the FDA include providing comprehensive plans for chemical and microbial testing of all drug product batches, including a review of reserve samples, and establishing a robust water system monitoring program. Kath Khemicals LLC must also detail how each component lot will be tested for identity, strength, quality, and purity, particularly for high-risk ingredients, and outline their program for qualifying suppliers and contract testing facilities.

Company
Kath Khemicals LLC
Inspection date
April 3, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 5b2f78c0-c705-4898-ac27-fd82b3070486

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21121 CFR 211.165(b)21 CFR 211.166(a)21 CFR 211.3421 CFR 210FD&C Act 501(a)(2)(B)21 CFR 211.165(a)21 CFR 211.84(d)(1)21 CFR 211.22

Full citation text and observation details available on the Dashboard.

Other documents for Kath Khemicals LLC
  • 483 - 2025-04-03April 3, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kath Khemicals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.